Login or Register
Biomedical Learning Institute Taught by the Experts
Thought Leaders
Biomedical Learning Institute
Please Note: The Oncology Learning Center has changed its name to Biomedical Learning Institute
Co-Chairs

Dr. Bunn
Paul A. Bunn, Jr., MD
James Dudley Chair in Cancer Research
Professor, Medical Oncology
University of Colorado Denver
Aurora, CO
Executive Director, International Association for the Study of Lung Cancer
(IASLC)

Dr. Bunn
Roy S. Herbst, MD, PhD
Chief, Section of Thoracic Oncology
Professor of Medicine & Cancer Biology
Department of Thoracic / Head & Neck Medical Oncology
Co-Director, Phase I Clinical Trials Working Group
The University of Texas
M. D. Anderson Cancer Center
Houston, TX

Dr. Bunn
Corey J. Langer, MD
Professor of Medicine
Director, Thoracic Oncology
Division of Hematology-Oncology
Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA
Vice Chair, Radiation Therapy Oncology Group
(RTOG)


Other Expert Faculty


Dr. Burtness
Barbara Burtness, MD
Chief, Head and Neck Medical Oncology
Department of Medical Oncology
Fox Chase Cancer Center
Philadelphia, PA


Dr. Curran
Walter J. Curran, MD, FACR
Professor and Chair
Department of Radiation Oncology
Emory School of Medicine Chief Medical Officer
Winship Cancer Institute
Atlanta, GA
Chairman, Radiation Therapy Oncology Group
(RTOG)


Dr. Heymach
John V. Heymach, MD, PhD
Assistant Professor of Thoracic Head/Neck Medical Oncology
Assistant Professor of Cancer Biology
The University of Texas
M. D. Anderson Cancer Center
Houston, TX


Dr. Kris
Mark G. Kris, MD
Chief, Thoracic Oncology Service
The William and Joy Ruane Chair in Thoracic Oncology
Memorial Sloan-Kettering Cancer Center
Professor of Medicine
Weill Medical College of Cornell University
New York NY


Dr. Ladanyi
Marc Ladanyi, MD
Chief, Molecular Diagnostics Service
Department of Pathology
Member, Human Oncology and Pathogenesis Program
Memorial Sloan-Kettering Cancer Center

Attending Pathologist
New York, NY


Dr. Lynch
Thomas J. Lynch, Jr., MD
Director, Yale Cancer Center
Physician-in-Chief,
Smilow Cancer Hospital, Yale-New Haven
New Haven, CT


Dr. Miller
Vincent A. Miller, MD
Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan-Kettering Cancer Center
New York, NY


Dr. Sandler
Alan B. Sandler, MD
Professor of Medicine
Division Chief, Hematology & Medical Oncology
DeArmond Chair, Clinical Cancer Research
Oregon Health & Science University
Portland, OR
Co-Chair, Eastern Cooperative Oncology Group
(ECOG)


Dr. Schiller
Joan H. Schiller, MD
Professor & Division Chief,
Hematology-Oncology
Deputy Director, Harold C. Simmons Cancer Center
Andrea L. Simons Distinguished Chair in Cancer Research
UT Southwestern Medical Center
Dallas, TX
Chair, Lung Committee, Eastern Cooperative Oncology Group
(ECOG)


Dr. Simon
George R. Simon, MD, FACP, FCCP
Director, Thoracic Oncology Program
Department of Medical Oncology
Fox Chase Cancer Center
Philadelphia, PA

Bookmark and Share
Personalized Lung Cancer

September 26, 2009 · Philadelphia, PA

Sheraton Philadelphia City Center Hotel

Taught by the top academic experts in lung cancer and head and neck cancer this is THE symposium on thoracic malignancies that you should attend in 2009. It contains the relevant data from the recent ASCO and the World Lung Cancer Congress. Personalized medicine for treating thoracic malignancies is a reality. This symposium will help clinicians improve their selection of the most appropriate therapeutics, and will also help clinicians to identify the patient sub-populations of lung cancer and head and neck cancer who will respond to specific drug therapies.

CO-CHAIRS

Paul A. Bunn, Jr., MD
James Dudley Chair in Cancer Research
Professor, Medical Oncology
University of Colorado Denver
Aurora, CO
Executive Director,
International Association for the Study of Lung Cancer
(IASLC)

Roy S. Herbst, MD, PhD
Chief, Section of Thoracic Oncology
Professor of Medicine & Cancer Biology
Department of Thoracic / Head & Neck Medical Oncology
Co-Director, Phase I Clinical Trials Working Group
The University of Texas, M. D. Anderson Cancer Center
Houston, TX

Corey J. Langer, MD
Professor of Medicine
Director, Thoracic Oncology
Division of Hematology-Oncology
Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA
Vice Chair, Radiation Therapy Oncology Group
(RTOG)

   
Overview
Educational Statement of Need
Disclosure
Target Audience
Learning Objectives
CME Credit Information
Methods of Participation
Agenda
Faculty
Sheraton Hotel
Registration
   

Disclosure Back to Top
DISCLOSURE STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) standards for Commercial Support, educational activities sponsored by the Oncology Learning Center (OLC) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, content and planning committee members participating in an OLC-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an OLC educational activity.

FACULTY/STAFF DISCLOSURE
Coming Soon.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration (FDA). The Oncology Learning Center (OLC) does not recommend the use of any agent outside of the FDA labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Oncology Learning Center. Please refer to the official FDA prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Educational Grants

Sincere appreciation is extended to the following companies for their generous support of this educational meeting:

Genentech
Eli Lilly
BMS
ImClone Systems
Boehringer Ingelheim
National Lung Cancer Partnership
AstraZeneca
Abraxis Oncology
Sanofi-Aventis
Poniard Pharmaceuticals
OSI Pharmaceuticals
Biodesix
OBR